/Investor DB

Innovative Solutions Canada — 2011 Investments

1 investments dated 2011 · listed companies and verified rows first · show all

Response Biomedical Corporationresponsebio.comin𝕏Dec 2011

Response Bio develops the RAMP platform, which delivers acute care diagnostic testing with lab-quality results within minutes to support rapid clinical decision-making in healthcare settings.

BiotechDigital HealthHealthtechMedical DevicesVancouver, CA

Anastasios Tsonis(Executive Officer)

BoardDr. Peter A. Thompson(Executive Officer, Director)Dr. Anthony F. Holler(Director)Clint Severson(Director)Dr. David Wang(Director)Lewis J. Shuster(Director)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.